FDA data Registry peer set 3 peers

Alternatives to linagliptin

3 same-class SPL records vs linagliptin - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

View linagliptin → All alternatives

Brand: Tradjenta

DPP-4 Inhibitor Prescription 3 alternatives found

About linagliptin

View full linagliptin profile →

3 DPP-4 Inhibitor peers (wide set)

alogliptin

Rx

Nesina

saxagliptin

Rx

Onglyza

sitagliptin

Rx

Januvia

Compare linagliptin vs alogliptin side-by-side →

linagliptin vs alogliptin & saxagliptin · FAERS reaction fields

FAERS top-reaction field "Blood Glucose Increased" shows the widest count spread between linagliptin and alogliptin, saxagliptin, sitagliptin in this extract (3,127-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect linagliptin alogliptinsaxagliptinsitagliptin
Blood Glucose Increased 1,326 86 401 4,453
Diarrhoea 1,196 134 328 3,470
Nausea 1,138 124 372 3,790
Fatigue 1,028 71 261 2,885
Dyspnoea 998 84 204 2,340
Dizziness 919 77 260 2,435
Vomiting 875 110 227 2,317
Malaise 789 93 - 1,898

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

linagliptin peer mix vs class inventory

Peer mix

0 OTC and 3 Rx SPL records in this peer set (3 total). Class inventory for DPP-4 Inhibitor: 4 drugs.

Frequently Asked Questions

What same-class SPL records sit beside linagliptin? ▼
This registry lists 3 DPP-4 Inhibitor medication records beside linagliptin, including alogliptin, saxagliptin, sitagliptin. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide DPP-4 Inhibitor peer set (3 records)

linagliptin (Tradjenta) sits in a wide DPP-4 Inhibitor peer set (3 of 3 class peers shown).

Top FAERS reaction fields for linagliptin total 9,786 reports across 10 reactions, set beside alogliptin, saxagliptin, sitagliptin. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full linagliptin profile →

Field note for linagliptin: see also the generic vs brand label guide when reading Tradjenta SPL strings.

Read our methodology - how this data is sourced, computed, and verified.